Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease.

Biotechnology

CajalNeuro

CajalNeuro's headquarters in Seattle, WA, United States

Andrew Dervan

Robert Hershberg

Alex Vaughan

Ian Peikon

Ben Logsdon

Valerie Huang

Niranjan Bose

Susan Hockfield

Rob Hershberg

Josh Wolfe

Tim Kutzkey

Martin Kampmann

Anthony Zador

Huda Zoghbi

Charles Zuker

Richard Hargreaves

Jay Shendure

David Holtzman

Martin Burke

The Research and Development team at CajalNeuro focuses on investigating the underlying mechanisms of neurodegenerative diseases through both experimental and computational approaches. They utilize advanced techniques in genomics, pharmacology, bioinformatics, and target validation to identify and develop potential therapeutic compounds. This multidisciplinary team works collaboratively to translate scientific discoveries into viable drug candidates, ultimately aiming to improve treatments for neurodegenerative conditions.

Research and Development

The Board Members at Cajal Neuroscience provide strategic oversight, governance, and high-level decision-making to guide the company's focus on drug discovery for neurodegenerative diseases. They influence key business directions, ensure financial sustainability, and support the executive leadership team in achieving long-term objectives.

Board Members

The Leadership Team at CajalNeuro is responsible for guiding the strategic direction and overall management of the company. They ensure alignment with the company’s mission to advance drug discovery for neurodegenerative diseases, and oversee key areas such as scientific research, corporate development, computational biology, and operational efficiency.

Leadership Team

The Corporate Development team at CajalNeuro is responsible for driving strategic initiatives, managing partnerships and alliances, overseeing procurement and financial operations, ensuring legal compliance, and fostering organizational growth to advance the company's mission in neurodegenerative drug discovery.

Corporate Development

The Software Development team at Cajal Neuroscience designs, develops, and maintains software systems to support drug discovery research for neurodegenerative diseases. This team ensures robust, scalable, and efficient solutions for data analysis, visualization, and computational biology needs, enhancing the overall research and development pipeline.

CajalNeuro

Org chart

Board & advisors

Teams

Research and Development

Board Members

Leadership Team

Corporate Development

Software Development

Offices

CajalNeuro

Org chart

Board & advisors

Teams

Research and Development

Board Members

Leadership Team

Corporate Development

Software Development

Offices

Related companies